Rituximab decreases the risk of lymphoma in patients with HIV-associated multicentric Castleman disease.
Saved in:
| Title: | Rituximab decreases the risk of lymphoma in patients with HIV-associated multicentric Castleman disease. |
|---|---|
| Authors: | Gérard L; Department of Clinical Immunology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, France. laurence.gerard@sls.aphp.fr, Michot JM, Burcheri S, Fieschi C, Longuet P, Delcey V, Meignin V, Agbalika F, Chevret S, Oksenhendler E, Galicier L |
| Source: | Blood [Blood] 2012 Mar 08; Vol. 119 (10), pp. 2228-33. Date of Electronic Publication: 2012 Jan 05. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
